Characteristics of preventive intervention acceptance for international travel among clients aged 60 years and older from a Japanese multicenter pretravel consultation registry.

International travel Japan Multicenter registry Older adults Pretravel consultation Travelers' vaccinations

Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 23 05 2023
revised: 13 08 2023
accepted: 17 08 2023
pubmed: 21 8 2023
medline: 21 8 2023
entrez: 20 8 2023
Statut: ppublish

Résumé

Pretravel consultation (PTC) is important for older adults owing to health problems associated with overseas travel. Although older adults in Japan, their PTC characteristics are less known. This study aimed to investigate the epidemiology of clients aged ≥ 60 years based on data from the Japan Pre-travel Consultation Registry (J-PRECOR). Clients aged ≥ 60 years who visited J-PRECOR cooperative hospitals from February 1, 2018, to May 31, 2022, were included. The primary endpoint was a comparison of prescriptions for vaccines for hepatitis A, tetanus toxoid, and malaria prophylaxis in travelers to high-risk malaria countries in yellow fever vaccination (YFV)-available facilities with and without YFV. In total, 1000 clients (median age: 67 years) were included. Although 523 clients were immunized with YFV, only 38.6% of the 961 unimmunized clients were vaccinated with the tetanus toxoid-containing vaccine. Malaria chemoprophylaxis was prescribed to 25.7% of clients traveling for ≤55 days. At YFV-capable institutes, 557 clients traveling to yellow fever risk countries took PTC, 474 of whom received YFV and 83 were unvaccinated. Lower age (odds rate 0.85 per 1 year; 95% CI 0.80-0.90) and lower hepatitis A vaccination rate (0.29; 95% CI 0.14-0.63) were significantly associated with YFV. Preventive interventions other than YFV should be offered to older adults.

Identifiants

pubmed: 37598777
pii: S1341-321X(23)00199-X
doi: 10.1016/j.jiac.2023.08.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1137-1144

Informations de copyright

Copyright © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest K.Y. received research grants from Fujirebio, Inc.; Mizuho Medy, Co., Ltd.; VisGene, Co., Ltd.; Canon Medical Systems, Corp.; Sanyo Chemical Industries, Ltd.; and CarbGeM Inc. Outside the submitted work. The authors therefore declare no conflicts of interest.

Auteurs

Kei Yamamoto (K)

Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan. Electronic address: kyamamoto@hosp.ncgm.go.jp.

Yusuke Asai (Y)

Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.

Hidenori Nakagawa (H)

Department of Infectious Diseases, Osaka City General Hospital, Osaka, 534-0021, Japan.

Issaku Nakatani (I)

Travel Clinic, Nara Seibu Hospital, Nara, 631-0061, Japan.

Kenichi Hayashi (K)

Department of Infectious Diseases, Kenwakai Otemachi Hospital, Kitakyushu, 803-0814, Japan.

Takashi Matono (T)

Department of Infectious Diseases, Aso Iizuka Hospital, Iizuka, 820-8505, Japan.

Shinichiro Kanai (S)

Department of Infection Control, Shinshu University Hospital, Matsumoto, 390-0802, Japan.

Masaya Yamato (M)

Department of General Medicine and Infectious Diseases, Travel Clinic, Rinku General Medical Center, Izumisano, 598-8577, Japan.

Takahiro Mikawa (T)

Department of General Medicine and Infectious Diseases, Yamanashi Prefectural Central Hospital, Kofu, 400-0027, Japan.

Michitsugu Shimatani (M)

Department of Infectious Diseases, Hamamatsu Medical Center, Hamamatsu, 432-8580, Japan.

Nobuyuki Shimono (N)

Center for the Study of Global Infection, Kyushu University Hospital, Fukuoka, 812-8582, Japan.

Koh Shinohara (K)

Department of Infectious Diseases, Kyoto City Hospital, Kyoto, 604-8845, Japan.

Tsuyoshi Kitaura (T)

Division of Infectious Diseases, Faculty of Medicine, Tottori University, Yonago, 683-8504, Japan.

Atsushi Nagasaka (A)

Department of Infectious Diseases, Sapporo City General Hospital, Sapporo, 060-8604, Japan.

Akihiro Manabe (A)

Department of Clinical Laboratory Medicine, Fukuyama City Hospital, Fukuyama, 721-8511, Japan.

Nobuhiro Komiya (N)

Department of Infectious Diseases, Japanese Red Cross Society Wakayama Medical Center, Wakayama, 640-8558, Japan.

Natsuko Imakita (N)

Center for Infectious Diseases, Nara Medical University Hospital, Kashihara, 634-8522, Japan.

Yoshihiro Yamamoto (Y)

Department of Clinical Infectious Diseases, Toyama University Hospital, Toyama, 930-0152, Japan.

Noriko Iwamoto (N)

Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.

Nobumasa Okumura (N)

Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.

Norio Ohmagari (N)

Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.

Classifications MeSH